Chris Gibson, Ph.D., is the CEO and Co-Founder of Recursion, a company rooted in his MD/PhD research at the University of Utah under Co-Founder Dr. Dean Li. He played a pivotal role in developing Recursion's technology and vision. Chris, a Rice University graduate with degrees in bioengineering and management, left medical school to lead Recursion's impressive growth. He's an advisor and mentor to emerging biotech founders and serves on the Board of BioHive, contributing to Utah's thriving life-science community. Chris also invests in life-science startups like Known Medicine, a venture that melds patient-specific 3D cell culture and AI for advancing drug development.